Human SCARB2 knockout MCF7 cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
SCARB2 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9; X = 1 bp insertion; Frameshift: 100%.
View Alternative Names
85 kDa lysosomal membrane sialoglycoprotein, 85 kDa lysosomal sialoglycoprotein scavenger receptor class B member 2, AMRF, CD36 antigen, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II), CD36 antigen-like 2, CD36L2, EPM4, HLGP85, LGP85, LIMP 2, LIMP II, Lysosomal integral membrane protein II, Lysosome membrane protein 2, Lysosome membrane protein II, OTTHUMP00000160590, OTTHUMP00000219176, SCRB2_HUMAN, SR BII, Scarb2, Scavenger receptor class B member 2
- WB
Lab
Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)
Lane 1 : Wild-type MCF7 cell lysate 20 μg
Lane 2 : SCARB2 knockout MCF7 cell lysate 20 μg
False colour image of Western blot : Anti-Scavenging Receptor SRB2 antibody [EPR12081] - C-terminal staining at 1/20000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab196651 was shown to bind specifically to Scavenging Receptor SRB2. A band was observed at 80 kDa in wild-type MCF7 cell lysates with no signal observed at this size in SCARB2 knockout cell line ab274952 (knockout cell lysate ab275010). To generate this image, wild-type and SCARB2 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-Scavenging Receptor SRB2 antibody [EPR12081] - C-terminal (<a href='/en-us/products/primary-antibodies/scavenging-receptor-srb2-antibody-epr12081-c-terminal-ab196651'>ab196651</a>) at 1/20000 dilution
Lane 1:
Wild-type MCF7 cell lysate at 20 µg
Lane 2:
SCARB2 knockout MCF7 cell lysate at 20 µg
Lane 2:
Western blot - Human SCARB2 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-scarb2-knockout-mcf7-cell-line-ab274952'>ab274952</a>)
Predicted band size: 54 kDa
Observed band size: 80 kDa
false
- WB
Lab
Western blot - Human SCARB2 knockout MCF7 cell lysate (AB275010)
Lane 1 : Wild-type MCF7 cell lysate 20 μg
Lane 2 : SCARB2 knockout MCF7 cell lysate 20 μg
Lane 3 : SH-SY5Y cell lysate 20 μg
Lane 4 : HEK-293 cell lysate 20 μg
False colour image of Western blot : Anti-LIMPII antibody [EPR12080] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab176317 was shown to bind specifically to LIMPII. A band was observed at 80 kDa in wild-type MCF7 cell lysates with no signal observed at this size in SCARB2 knockout cell line ab274952 (knockout cell lysate ab275010). To generate this image, wild-type and SCARB2 knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-LIMPII antibody [EPR12080] (<a href='/en-us/products/primary-antibodies/limpii-antibody-epr12080-ab176317'>ab176317</a>) at 1/1000 dilution
Lane 1:
Wild-type MCF7 cell lysate at 20 µg
Lane 2:
SCARB2 knockout MCF7 cell lysate at 20 µg
Lane 2:
Western blot - Human SCARB2 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-scarb2-knockout-mcf7-cell-line-ab274952'>ab274952</a>)
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
HEK-293 cell lysate at 20 µg
Predicted band size: 54 kDa
Observed band size: 80 kDa
false
- NGS
Supplier Data
Next Generation Sequencing - Human SCARB2 knockout MCF7 cell lysate (AB275010)
Knockout achieved by CRISPR/Cas9; X = 1 bp insertion; Frameshift : 100%
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein plays a critical role in lipid and protein degradation and helps maintain cellular homeostasis. As part of the lysosomal membrane LIMPII facilitates the uptake and processing of large biomolecules into the lysosome. It functions as a receptor for the uptake of β-glucocerebrosidase forming a complex to assist in its proper delivery from the endoplasmic reticulum to the lysosomes. This receptor-ligand relationship ensures efficient enzymatic activity necessary for lipid metabolism.
Pathways
One finds that LIMPII participates in the sphingolipid metabolism pathway and is vital for glucosylceramide catabolism. It interacts with glucocerebrosidase in this pathway which plays a significant role in the metabolism of glycosphingolipids. Another pathway where LIMPII has importance is the autophagy pathway where it contributes to the fusion of autophagosomes with lysosomes. Its activity supports the turnover of cellular components maintaining cellular metabolic balance.
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com